NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 109 filers reported holding NEVRO CORP in Q3 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $31,000 | +82.4% | 255 | +26.2% | 0.00% | – |
Q3 2019 | $17,000 | +54.5% | 202 | +21.7% | 0.00% | – |
Q2 2019 | $11,000 | -76.6% | 166 | -78.0% | 0.00% | – |
Q1 2019 | $47,000 | +88.0% | 753 | +10.7% | 0.00% | – |
Q4 2018 | $25,000 | -39.0% | 680 | -5.7% | 0.00% | – |
Q3 2018 | $41,000 | -80.5% | 721 | -70.4% | 0.00% | -100.0% |
Q2 2018 | $210,000 | 0.0% | 2,432 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $210,000 | +112.1% | 2,432 | +69.7% | 0.00% | +100.0% |
Q4 2017 | $99,000 | +350.0% | 1,433 | +487.3% | 0.00% | – |
Q3 2017 | $22,000 | +83.3% | 244 | +49.7% | 0.00% | – |
Q2 2017 | $12,000 | -33.3% | 163 | -15.5% | 0.00% | – |
Q1 2017 | $18,000 | +28.6% | 193 | +10.9% | 0.00% | – |
Q4 2016 | $14,000 | +100.0% | 174 | +152.2% | 0.00% | – |
Q3 2016 | $7,000 | -76.7% | 69 | -83.0% | 0.00% | – |
Q2 2016 | $30,000 | +30.4% | 407 | 0.0% | 0.00% | – |
Q1 2016 | $23,000 | -14.8% | 407 | +1.8% | 0.00% | – |
Q4 2015 | $27,000 | +42.1% | 400 | 0.0% | 0.00% | – |
Q3 2015 | $19,000 | -13.6% | 400 | 0.0% | 0.00% | – |
Q2 2015 | $22,000 | +15.8% | 400 | 0.0% | 0.00% | – |
Q1 2015 | $19,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 622,615 | $38,920,000 | 8.04% |
Tamarack Advisers, LP | 160,000 | $10,002,000 | 3.97% |
Birch Run Capital Advisors, LP | 187,425 | $11,716,000 | 3.72% |
Prosight Management, LP | 128,765 | $8,049,000 | 3.52% |
Ratan Capital Management LP | 38,653 | $2,416,000 | 3.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 579,463 | $36,222,000 | 1.39% |
Spark Investment Management LLC | 403,400 | $25,216,000 | 1.17% |
Sivik Global Healthcare LLC | 50,000 | $3,126,000 | 1.15% |
ArrowMark Colorado Holdings LLC | 1,882,009 | $117,644,000 | 1.11% |
PFM Health Sciences, LP | 721,229 | $45,084,000 | 1.00% |